Skip to main content

Table 2 Patient reported migraine disability individual item scores (mean [SD]) by preventive treatment eligibility status

From: A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe

MIDAS individual items, mean (SD) US   EUa    Total (US + EU)
  Preventive Eligibleb
(n = 584)
Preventive Non- Eligiblec (n = 789) Preventive Eligibleb
(n = 1942)
Preventive Non- Eligiblec (n = 2147) Preventive Eligibleb (n = 2526) Preventive Non- Eligiblec (n = 2936)
Number of days missed work or school 1.5 (2.4) 0.7 (1.5) 1.7 (4.6) 0.7 (1.5) 1.7 (4.1) 0.7 (1.5)
Number of days with reduced productivity by half or more at work or school 2.9 (7.0) 1.0 (1.9) 2.8 (5.4) 1.5 (3.0) 2.8 (5.9) 1.4 (2.7)
Number of days missed of household work 4.6 (9.5) 1.6 (4.3) 4.0 (7.1) 1.9 (3.0) 4.2 (7.8) 1.8 (3.5)
Number of days with reduced productivity by half or more in household work 4.7 (9.2) 1.5 (3.1) 4.2 (7.0) 2.3 (3.7) 4.3 (7.6) 2.0 (3.6)
Number of days missed family or social events 2.2 (3.3) 1.1 (2.2) 3.0 (4.1) 1.6 (2.5) 2.8 (3.9) 1.4 (2.4)
  1. p < 0.0001 for comparisons between preventive eligible and preventive non-eligible
  2. aEuropean (EU) countries included: Germany, France, Spain, Italy and, the UK
  3. bPreventive Eligible was defined as > 4 migraine headache days per month. cPreventive Non-Eligible was defined as < 4 migraine headache days/month
  4. Preventive eligibility groups derived from PRF data; MIDAS is a patient reported outcome tool included in the patient self-completion form and so individual bases are lower
  5. Abbreviations: MIDAS Migraine-Disability Assessment Score, SD Standard deviation